Contemporary review of primary membranous nephropathy
Edward J. Filippone, John L. Farber · 2026
Read Contemporary review of primary membranous nephropathy by Edward J. Filippone, John L. Farber (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13327930.txt.
Description
Edward J Filippone and John L Farber give a contemporary review of primary membranous nephropathy in a 2026 article. The kidney disease is an autoimmune attack on podocyte targets, most often the PLA2R receptor. Fourteen other targets are now known, and the culprit stays hidden in 5 to 10 percent of cases. It usually appears as nephrotic syndrome.
About a third of patients remit on their own, a third head toward kidney failure, and the rest keep leaking protein, so treatment follows risk level. Low-risk patients can be watched, the highest-risk receive alternating steroids and cyclophosphamide, and mid-to-high-risk patients get rituximab with a 60 to 80 percent response expected on their summary. Antibody levels guide follow-up and flag relapse.
Catalog record
| CREATOR | Edward J. Filippone, John L. Farber |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 100478 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |